Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001209191-16-122818
Filing Date
2016-05-24
Accepted
2016-05-24 12:00:49
Documents
1
Effectiveness Date
2016-05-24
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 14331
  Complete submission text file 0001209191-16-122818.txt   15771
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-263727 | Film No.: 161671181
SIC: 2834 Pharmaceutical Preparations